An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics (Q34310967)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics |
scientific article |
Statements
1 reference
An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics (English)
1 reference
Mary Burnell-Nugent
1 reference
Jeremy R Johnson
1 reference
Dominique Lossignol
1 reference
Marie T Fallon
1 reference
8 November 2012
1 reference
1 reference
46
1 reference
2
1 reference
207-218
1 reference
Identifiers
1 reference
1 reference